CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
TherACCage aims to create advanced artificial cells using drug-loaded molecular cages to improve treatment for glioblastoma multiforme, a deadly brain tumor. By recognizing specific biomarkers in the tumor microenvironment, these nanosystems will enable targeted drug delivery, enhancing therapeutic efficacy and reducin…
Cancer is still a major societal challenge, as reflected by the Horizon's Europe mission on cancer and the Europe's Beating Cancer Plan.
In particular, despite great advances in cancer treatment in recent decades, glioblastoma multiform (GBM) - the most common malignant brain tumor - stills remains without an effective cure and patients die in a few months.
Around 220000 people die annually worldwide from GBM and its incidence is expected to increase in Europe due to its aging population.
The st…
UNIVERSITAT POLITECNICA DE VALENCIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
